Box score
EnteroBiotix LTD
Reported $5.3M sold in a new Form D filed April 9, 2026 (Glasgow, outside the US).
- Biggest raise
- $5.3M filed Apr 9, 2026
- League
- Bio & Health Biotechnology
- Based in
- Glasgow, outside the US
- Season rank
- #308 of 1,121 in the Bio & Health League; #2705 of 10,745 overall (2026)
- Entity
- Other
Form D filings since 2024 4
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-04-09 | New notice | $5.3M | indefinite | SEC |
| 2025-07-25 | New notice | $1.4M | indefinite | SEC |
| 2024-04-09 | New notice | $1.3M | indefinite | SEC |
| 2024-02-02 | New notice | $2.6M | indefinite | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1946072.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Regentis Biomaterials Ltd. rookie | Bio & Health | $6.5M |
| 2 | Federated Biologics Inc. rookie | Bio & Health | $6M |
| 3 | CASI Pharmaceuticals, Inc. | Bio & Health | $5M |
| 4 | CASI Pharmaceuticals, Inc. | Bio & Health | $5M |
| 5 | CASI Pharmaceuticals, Inc. | Bio & Health | $5M |
| 6 | CASI Pharmaceuticals, Inc. | Bio & Health | $5M |